| Product Code: ETC9971406 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Dhaval Chaurasia | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 United States (US) Neuroscience Market Overview |
3.1 United States (US) Country Macro Economic Indicators |
3.2 United States (US) Neuroscience Market Revenues & Volume, 2021 & 2031F |
3.3 United States (US) Neuroscience Market - Industry Life Cycle |
3.4 United States (US) Neuroscience Market - Porter's Five Forces |
3.5 United States (US) Neuroscience Market Revenues & Volume Share, By Component, 2021 & 2031F |
3.6 United States (US) Neuroscience Market Revenues & Volume Share, By Technology, 2021 & 2031F |
3.7 United States (US) Neuroscience Market Revenues & Volume Share, By End-user, 2021 & 2031F |
4 United States (US) Neuroscience Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of neurological disorders in the US |
4.2.2 Advancements in neuroscience research and technology |
4.2.3 Growing demand for personalized medicine and targeted therapies in neurology |
4.3 Market Restraints |
4.3.1 High cost of neuroscience treatments and therapies |
4.3.2 Stringent regulatory requirements for neurology drugs and devices |
4.3.3 Limited access to specialized neuroscience healthcare services in certain regions of the US |
5 United States (US) Neuroscience Market Trends |
6 United States (US) Neuroscience Market, By Types |
6.1 United States (US) Neuroscience Market, By Component |
6.1.1 Overview and Analysis |
6.1.2 United States (US) Neuroscience Market Revenues & Volume, By Component, 2021- 2031F |
6.1.3 United States (US) Neuroscience Market Revenues & Volume, By Instrument, 2021- 2031F |
6.1.4 United States (US) Neuroscience Market Revenues & Volume, By Software, 2021- 2031F |
6.1.5 United States (US) Neuroscience Market Revenues & Volume, By Services, 2021- 2031F |
6.2 United States (US) Neuroscience Market, By Technology |
6.2.1 Overview and Analysis |
6.2.2 United States (US) Neuroscience Market Revenues & Volume, By Whole Brain Imaging, 2021- 2031F |
6.2.3 United States (US) Neuroscience Market Revenues & Volume, By Neuro-microscopy, 2021- 2031F |
6.2.4 United States (US) Neuroscience Market Revenues & Volume, By Electrophysiology, 2021- 2031F |
6.2.5 United States (US) Neuroscience Market Revenues & Volume, By Neuroproteomics Analysis, 2021- 2031F |
6.2.6 United States (US) Neuroscience Market Revenues & Volume, By Animal Behavior Analysis, 2021- 2031F |
6.2.7 United States (US) Neuroscience Market Revenues & Volume, By Neuro-functional Analysis, 2021- 2031F |
6.3 United States (US) Neuroscience Market, By End-user |
6.3.1 Overview and Analysis |
6.3.2 United States (US) Neuroscience Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.3.3 United States (US) Neuroscience Market Revenues & Volume, By Diagnostic Laboratories, 2021- 2031F |
6.3.4 United States (US) Neuroscience Market Revenues & Volume, By Academic & Research Institutions, 2021- 2031F |
6.3.5 United States (US) Neuroscience Market Revenues & Volume, By Others, 2021- 2031F |
7 United States (US) Neuroscience Market Import-Export Trade Statistics |
7.1 United States (US) Neuroscience Market Export to Major Countries |
7.2 United States (US) Neuroscience Market Imports from Major Countries |
8 United States (US) Neuroscience Market Key Performance Indicators |
8.1 Number of clinical trials and research studies in neuroscience conducted in the US |
8.2 Adoption rate of novel neurology treatments and technologies in the US healthcare system |
8.3 Investment inflow into US-based neuroscience startups and companies |
8.4 Number of neurologists and neuroscience specialists per capita in the US |
8.5 Patient satisfaction and outcomes measures for neurology treatments in the US |
9 United States (US) Neuroscience Market - Opportunity Assessment |
9.1 United States (US) Neuroscience Market Opportunity Assessment, By Component, 2021 & 2031F |
9.2 United States (US) Neuroscience Market Opportunity Assessment, By Technology, 2021 & 2031F |
9.3 United States (US) Neuroscience Market Opportunity Assessment, By End-user, 2021 & 2031F |
10 United States (US) Neuroscience Market - Competitive Landscape |
10.1 United States (US) Neuroscience Market Revenue Share, By Companies, 2024 |
10.2 United States (US) Neuroscience Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here